These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


306 related items for PubMed ID: 32725244

  • 1. Cost-effectiveness of a Stepwise Approach vs Standard Care for Diabetes Prevention in India.
    Islek D, Weber MB, Ranjit Mohan A, Mohan V, Staimez LR, Harish R, Narayan KMV, Laxy M, Ali MK.
    JAMA Netw Open; 2020 Jul 01; 3(7):e207539. PubMed ID: 32725244
    [Abstract] [Full Text] [Related]

  • 2. Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes.
    Eddy DM, Schlessinger L, Kahn R.
    Ann Intern Med; 2005 Aug 16; 143(4):251-64. PubMed ID: 16103469
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Evaluating the cost-effectiveness of lifestyle modification versus metformin therapy for the prevention of diabetes in Singapore.
    Png ME, Yoong JS.
    PLoS One; 2014 Aug 16; 9(9):e107225. PubMed ID: 25203633
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cost-effectiveness of the interventions in the primary prevention of diabetes among Asian Indians: within-trial results of the Indian Diabetes Prevention Programme (IDPP).
    Ramachandran A, Snehalatha C, Yamuna A, Mary S, Ping Z.
    Diabetes Care; 2007 Oct 16; 30(10):2548-52. PubMed ID: 17670917
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effectiveness and cost-effectiveness of diabetes prevention among adherent participants.
    Herman WH, Edelstein SL, Ratner RE, Montez MG, Ackermann RT, Orchard TJ, Foulkes MA, Zhang P, Saudek CD, Brown MB, Diabetes Prevention Program Research Group.
    Am J Manag Care; 2013 Oct 16; 19(3):194-202. PubMed ID: 23544761
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Lifestyle Intervention With or Without Lay Volunteers to Prevent Type 2 Diabetes in People With Impaired Fasting Glucose and/or Nondiabetic Hyperglycemia: A Randomized Clinical Trial.
    Sampson M, Clark A, Bachmann M, Garner N, Irvine L, Howe A, Greaves C, Auckland S, Smith J, Turner J, Rea D, Rayman G, Dhatariya K, John WG, Barton G, Usher R, Ferns C, Pascale M, Norfolk Diabetes Prevention Study (NDPS) Group.
    JAMA Intern Med; 2021 Feb 01; 181(2):168-178. PubMed ID: 33136119
    [Abstract] [Full Text] [Related]

  • 19. Assessing the cost-effectiveness of drug and lifestyle intervention following opportunistic screening for pre-diabetes in primary care.
    Bertram MY, Lim SS, Barendregt JJ, Vos T.
    Diabetologia; 2010 May 01; 53(5):875-81. PubMed ID: 20135088
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.